文献速递呼吸危重症与机械通气

真实世界队列中家庭无创通气成功启动的定义与现状

Defining successful non-invasive ventilation initiation: Data from a real-life cohort.
PubMed 文献 · Respirology · 2021-07-26

随访时141例(56%)有五项完整数据,仅12例(9%)达到全部目标(成功启动),96例(68%)达到至少三项(充分启动)。潮气量≥7.8 ml/kg理想体重与充分启动相关(HR:5.765,95%CI:1.824-18.223,p=0.006)。

要点

  • 真实世界中家庭NIV成功启动(五项全达标)仅9%,充分启动(≥三项)为68%。
  • 潮气量≥7.8 ml/kg理想体重与充分启动独立相关(HR 5.765)。
  • 中重度NIV副作用见于47%患者,且与日间PaCO2较高相关。

核心结论

  • 真实世界中家庭NIV成功启动(五项全达标)仅9%,充分启动(≥三项)为68%。
  • HRQL与睡眠质量改善不随日间PaCO2改善而同步变化。
  • 应评估HRQL与NIV耐受性以改善以患者为中心的结局。

研究设计与样本

  • HRQL采用严重呼吸功能不全问卷在基线与随访时评估。
  • 充分启动定义为五项目标中至少达成三项,成功启动定义为五项全部达成。

主要发现

  • 启动NIV的病因构成:肥胖低通气综合征95例(38%)、神经肌肉疾病70例(28%)、慢阻肺66例(26%)、胸壁疾病19例(8%)。
  • 随访时141例(56%)患者五项目标均有完整测量。
  • 充分启动96例(68%),成功启动12例(9%)。
  • 多因素分析中潮气量≥7.8 ml/kg理想体重与充分启动可能性增加相关(HR:5.765 [95%CI:1.824-18.223],p=0.006)。
  • 日间PaCO2改善与HRQL或睡眠质量改善无相关性。

关键数值与推荐

  • 五项启动目标:每日使用>4 h/天、气体交换改善、HRQL改善、睡眠质量改善、无副作用。
  • 充分启动:至少达成五项中的三项;成功启动:五项全部达成。
  • 中重度NIV相关副作用发生于114例(47%),与较高的日间PaCO2相关(6.35 ± 1.08 vs. 5.92 ± 0.79 kPa,p < 0.001)。

临床怎么用

  • 启动家庭NIV时应系统评估五项预设目标而非仅关注气体交换。
  • 潮气量≥7.8 ml/kg理想体重与充分启动相关,可作为启动参数参考。
  • 需常规监测HRQL与NIV副作用以提升以患者为中心的结局。

局限性

  • 单中心设计可能限制结果外推。
  • 仅56%患者随访时具备五项完整数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: When home non-invasive ventilation (NIV) is initiated, five goals need to be achieved: a daily use >4 h/day, an improvement in gas exchange, health-related quality of life (HRQL) and sleep quality without side effects. Our aim was to assess how frequently these five goals were reached and the factors predictive of achievement. METHODS: We conducted a monocentric cohort study that included patients electively established on home NIV over 2 years. HRQL was assessed at baseline and follow-up by the Severe Respiratory Insufficiency questionnaire. Adequate initiation was defined as the achievement of at least three of five goals and successful initiation as the achievement of all. RESULTS: Two-hundred and fifty patients were included at baseline. NIV was initiated for: obesity hypoventilation syndrome (n = 95; 38%), neuromuscular disease (n = 70; 28%), chronic obstructive pulmonary disease (n = 66; 26%) and chest wall disease (n = 19; 8%). At follow-up, measures of all five goals were available in 141 (56%) patients. NIV initiation was adequate for 96 (68%) patients and successful for 12 (9%) patients. In multivariate analysis, a tidal volume ≥ 7.8 ml/kg of ideal body weight was associated with an increased likelihood of adequate NIV initiation (hazard ratio: 5.765 [95% CI:1.824-18.223], p = 0.006]. Improvement in daytime partial arterial carbon dioxide pressure (PaCO2 ) was not correlated to improvement in HRQL or sleep quality. Severe to very severe NIV-related side effects occurred in 114 (47%) patients and were associated with higher daytime PaCO2 (6.35 ± 1.08 vs. 5.92 ± 0.79 kPa, p < 0.001). CONCLUSION: Successful home NIV initiation is rarely achieved in real life. HRQL and NIV tolerance should be assessed to improve patient-centred outcomes.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Jolly G, Razakamanantsoa L, Fresnel E, et al. Defining successful non-invasive ventilation initiation: Data from a real-life cohort. Respirology. 2021. PMID: 34312942. doi:10.1111/resp.14118

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。